A Study Evaluating the Safety, Tolerability, and Activity of ICM-203 in Subjects With Knee Osteoarthritis.
NCT05454566 is a phase 1/2 interventional trial sponsored by ICM Co. Ltd.. As of 21 Nov 2026, it was withdrawn. It studies Osteoarthritis, Knee. The registry lists an enrollment of 0 participants. The registry lists a start date of 15 Nov 2026 and a primary completion date of 15 May 2027.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT05454566 |
| Status | Withdrawn |
| Phase | Phase 1/2 |
| Study type | Interventional trial |
| Lead sponsor | ICM Co. Ltd. |
| Enrollment | 0 |
| Conditions | Osteoarthritis, Knee |
| Start | 15 Nov 2026 |
| Primary completion | 15 May 2027 |
| Study completion | 15 Nov 2028 |
| Last update posted | 8 Sept 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Alison Heald, MD
ICM Co. Ltd.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT05454566
Each answer restates registry values shown on this page.
What is NCT05454566?
NCT05454566 is a phase 1/2 interventional trial sponsored by ICM Co. Ltd.. It studies Osteoarthritis, Knee.
Who leads NCT05454566?
The registry names Alison Heald, MD (study director, ICM Co. Ltd.) as the overall official.
When did NCT05454566 end?
The registry lists a primary completion date of 15 May 2027 and a study completion date of 15 Nov 2028. The sponsor last updated the record on 8 Sept 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.